Overview
- Discusses both positive and negative findings
- Describes studies of diseases not commonly thought of as having metabolic links or origins
- Looks at economic aspects of these diseases and the benefits of using biomarkers for the healthcare systems
Part of the book series: Advances in Experimental Medicine and Biology (AEMB, volume 1134)
Part of the book sub series: Proteomics, Metabolomics, Interactomics and Systems Biology (PMISB)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (15 chapters)
-
Front Matter
-
Back Matter
Keywords
About this book
The book recognizes that throughout the scientific, medical, and economic communities, new tests incorporating biomarkers are needed to improve the diagnosis of patients suffering from metabolic disorders. The early identification of those at risk of developing obesity will help to place these individuals on the best treatment course as early as possible for improved treatment outcomes. This will also help to cut costs incurred by the healthcare services. For all of this to occur, new research efforts are needed to identify novel biomarkers that can be used to predict the disease in the presymptomatic stage, for disease monitoring and for prediction of treatment response. It is also possible that new drug targets can be identified using these approaches which, in turn, can lead to the development of new treatment approaches. This volume also includes a series of reviews on biomarker discovery and usage in the study of diseases marked by perturbations in metabolism. It will describe the pros and cons of the various approaches and cover the successes and failures in this important research field.
Editors and Affiliations
About the editor
Bibliographic Information
Book Title: Reviews on Biomarker Studies of Metabolic and Metabolism-Related Disorders
Editors: Paul C. Guest
Series Title: Advances in Experimental Medicine and Biology
DOI: https://doi.org/10.1007/978-3-030-12668-1
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2019
Hardcover ISBN: 978-3-030-12667-4Due: 08 April 2019
Softcover ISBN: 978-3-030-12670-4Published: 14 August 2020
eBook ISBN: 978-3-030-12668-1Published: 27 March 2019
Series ISSN: 0065-2598
Series E-ISSN: 2214-8019
Edition Number: 1
Number of Pages: XI, 303
Number of Illustrations: 17 b/w illustrations, 22 illustrations in colour
Topics: Proteomics, Gene Function, Diabetes